Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × 90 days × Clear all

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT05501704 2026-01-07

ETHAN - ET for Male BC

Phase 2 Recruiting

Breast Neoplasms, Male